ARTICLE | Company News
MorphoSys licenses MOR103 to GSK
June 4, 2013 2:56 AM UTC
MorphoSys AG (Xetra:MOR; Pink:MPSYF) granted GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) exclusive, worldwide rights to develop and commercialize MOR103. MorphoSys will receive EUR 22.5 million ($29.3 mil...